ANNUAL REPORT 2024

Founded in 1951, ACOG is the premier professional membership organization for obstetrician–gynecologists. The College produces practice guidelines for health care professionals and educational materials for patients, provides practice management and career support, facilitates programs and initiatives to improve women’s health, and advocates for members and patients.
With more than 60,000 members spanning the entire career life cycle, ACOG is composed of 12 Districts. These Districts are made up of 93 Sections. ACOG’s Districts and Sections represent various regions, countries, territories, and states in North and South America.
ACOG Fellows are board-certified obstetrician-gynecologists whose professional activities are devoted to the practice of obstetrics and gynecology, who possess unrestricted licenses to practice medicine, and who have attained high ethical and professional standing.
Mission
ACOG’s mission is to support our members to improve the lives of all people seeking obstetric and gynecologic care, their families, and communities.
Vision
ACOG’s vision is an equitable world in which exceptional and respectful obstetric and gynecologic care is accessible to all.
Excellence
Integrity
Accountability
Respect
Equity
LETTER FROM THE ACOG PRESIDENT AND CHIEF EXECUTIVE
OFFICER
Dear ACOG family and valued supporters,
Over the last year, we at ACOG worked to empower our members to sustain, maintain, and pursue rewarding practices as ob-gyns and support them in their efforts to provide compassionate, patientcentered care in their communities. Ob-gyns care for their patients across their life span; provide critical high-risk obstetric care and prevention and treatment of gynecologic malignancies; fulfill people’s dreams of growing their families; and facilitate fertility treatments, all in an increasingly challenging environment. This is no small task, as the practice of obstetrics and gynecology has never been more complex. However, we remain undaunted in our commitment to you, as we know how important our specialty is to the health and well-being of people and families.
As ACOG implements innovative approaches to make meaningful improvements in our members’ practices and careers—and, concurrently, in our patients’ health and lives—we also seek to continuously provide a community for our members on which they can rely for support, training, networking, and professional development. We partner with our members to advocate for equitable payment; the sanctity of the patient–physician relationship; and combat misinformation to promote science, evidence, and the truth.
We who are drawn to the field of obstetrics and gynecology share a calling. By recognizing the purpose that drives us all, we create a community that is supportive, uplifting, inspiring, and sustaining.
As we near ACOG’s 75th anniversary, we reflect on the enduring commitment of our organization to our members and their patients. It is our goal for all of our members—across all practice models, settings, and stages in their careers—to find, maintain, or rediscover joy in the practice of medicine and for their patients to be able to receive the comprehensive, evidence-based care that they need. We will continue to do our best to pave the way for that to happen.
Looking back at 2024, we are humbled by all that we were able to achieve through collaboration with our membership, with partners who share our commitment to advancing patient care, and with other stakeholders who are driven to achieve a more sustainable environment for obstetric and gynecologic care. We look forward to continuing this critical work together.
Stella Dantas, MD, FACOG 75th ACOG President
“Our ACOG community is dynamic, dedicated, and inspiring. ACOG is strengthened every day by the work we do for—and with—our members.”
Sandra E. Brooks, MD, MBA, FACOG ACOG CEO
“It is my deep honor and privilege to lead this highly respected organization with our deeply committed leaders and staff. Our focus on our mission is unwavering.”
ResearchLetter
ValidityofBirthCertificateDataCompared WithHospitalDischargeDatainReporting
NarrativeReview
MaternalMorbidityandDisparities AlisonGemmill,PhD,MollyPassarella,MS,CiaranS.Phibbs,PhD,ElliottK.Main,MD ScottA.Lorch,MD,KatyB.Kozhimannil,PhD,SuzanL.Carmichael,PhD,andStephanieA.Leonard,PhD
RichardM.Burwick, MD MPH,andM.HellenRodriguez, MD Preeclampsiacontributesdisproportionatelytomaternal andneonatalmorbidityandmortalitythroughoutthe world.Acriticaldriverofpreeclampsiaisangiogenic imbalance,whichisoftenpresentweekstomonths beforeovertdisease.Twoplacenta-derivedangiogenic biomarkers,solublefms-liketyrosinekinase1(sFlt-1) andplacentalgrowthfactor(PlGF),haveprovedusefulas diagnosticandprognostictestsforpreeclampsia. Recently,theU.S.FoodandDrugAdministration approvedthesFlt-1/PlGFassaytoaidintheprediction ofpreeclampsiawithseverefeaturesamongwomenwith hypertensivedisordersofpregnancyat24–34weeksof gestation.Inthisnarrativereview,wesummarizethe bodyofworkleadingtothisapprovalanddescribe howthesFlt-1/PlGFratiomaybeimplementedinclinical practiceasanadjunctivemeasuretohelpoptimizecare andtoreduceadverseoutcomesinpreeclampsia. (ObstetGynecol2024;143:515–23) DOI:10.1097/AOG.0000000000005532 Preeclampsiaisalife-threateninghypertensivedisorderthatcomplicates3–4%ofallpregnanciesin theUnitedStates.1,2 Itisaglobalpublichealthconcern, withmorethan70,000maternaldeathsattributedto preeclampsiaannually.3,4 Maternalandneonatalmorbidityandmortalityincreasesignificantlywhensevere featuresofdiseasearepresent(Box1)becausethey portendend-organinjuryandadverseoutcomes.5,6 Surveillanceforseverefeaturesinat-riskpatientsis
OriginalResearch
criticaltoinformhospitalizationandtreatmentdecisionsandtoexpeditedelivery,whennecessary,topreventfetaldeathandmaternalcomplications.7,8Althoughpreeclampsiawithseverefeaturesmay arisesuddenly,itisoftenprecededbyanonsevere hypertensivedisorderofpregnancy,includinggestationalhypertension,preeclampsiawithoutsevere features,orchronichypertensionwithorwithout superimposedpreeclampsia.9,10 Suchpatientsare oftenhospitalizedinthelasthalfofpregnancytoevaluateforseverefeaturesthroughassessmentofblood pressure,clinicalsymptoms(eg,headache,visualdisturbances),andlaboratoryparameters(eg,liver enzymes,plateletcount).Theseevaluationsareused tomakeimportantclinicaldecisions,yettheyhave limitedabilitytopredictseverediseaseandadverse outcomesinthesubsequentdaysandweeks.11,12 Box1.PreeclampsiaWithSevereFeatures Systolicbloodpressureof160mmHgormore,or diastolicbloodpressureof110mmHgormoreon twooccasionsatleast4hoursapart(unlessantihypertensivetherapyisinitiatedbeforethistime) Thrombocytopenia(plateletcountlessthan100310 L)Impairedliverfunctionthatisnotaccountedforby alternativediagnosesandasindicatedbyabnormally elevatedbloodconcentrationsofliverenzymes(to morethantwicetheupperlimitnormalconcentrations)orbyseverepersistentupperrightquadrantor epigastricpainunresponsivetomedications Renalinsufficiency(serumcreatinineconcentration morethan1.1mg/dLoradoublingofserumcreatinineconcentrationintheabsenceofotherrenal disease) Pulmonaryedema New-onsetheadacheunresponsivetomedicationand notaccountedforbyalternativediagnoses Visualdisturbances ReprintedfromGestationalhypertensionandpreeclampsia. ACOGPracticeBulletinNo.222.AmericanCollegeof ObstetriciansandGynecologists.ObstetGynecol 2020;135:e237–60.doi:10.1097/AOG.0000000000003891.5
Late-PretermAntenatalSteroidsfor ReductionofNeonatal RespiratoryComplications
ARandomizedControlledTrial
ResearchLetter
HildaYenuberi, MD,BenjaminRoss, DM,RichaSasmitaTirkey, MS,SantoshJosephBenjamin, MS SwatiRathore, MS,RekaKaruppusami, MSc,AadarshLal, MSc,NiranjanThomas, MD, FRACP
Agrowingnumberofstudiesareusingbirthcertificate data,despitedata-qualityconcerns,tostudymaternal morbidityandassociateddisparities.Weexamined whetherconclusionsabouttheincidenceofmaternal morbidity,includingBlack–Whitedisparities,differ betweenbirthcertificatedataandhospitalizationdata. Usinglinkedbirthcertificateandhospitalizationdata fromCaliforniaandMichiganfor2018(N5543,469), wefoundthatmaternalmorbiditymeasuresusing birthcertificatedataalonearesubstantiallyunderreportedandhavepoorvalidity.Furthermore,the degreeofunderreportinginbirthcertificatedatadiffersbetweenBlackandWhiteindividualsandresults inerroneousinferencesaboutdisparities.Overall, Black–Whitedisparitiesweremoremodestinthebirth certificatedatacomparedwiththehospitalization data.Birthcertificatedataaloneareinadequatefor studiesofmaternalmorbidityandassociatedracial disparities.(ObstetGynecol2024;143:459–62) DOI:10.1097/AOG.0000000000005497 Preventingseverematernalmorbidity(SMM)and andpolicyinterest.associateddisparitieshasgarneredintenseclinical 1 TheCentersforDiseaseControl andPrevention(CDC)identifiesSMMinadministrativedatabasedonatleast1of21indicatorsofpotentiallylife-threateningeventsoccurringduringlabor anddelivery.2 Theseindicatorsareidentifiedusing InternationalClassificationofDiseasesdiagnosisand procedurecodes.3 Nationalhospitalizationdatawith thesecodes(eg,NationalInpatientSample)canbe cost-prohibitivetoaccess,arenotreadilyavailableat thestatelevel,andhaveincompleteinformationon raceandethnicity.Birthcertificatedata,bycontrast, arefreelyavailable,includenearlyallbirthsinthe UnitedStates,andcontainself-reportedraceandethnicity.Anincreasingnumberofstudiespublishedin high-impactjournalsaremeasuringmaternalmorbidityusingonlydatafromthebirthcertificate,4–6 becauseallstates(since2014)haveimplementeda revisedbirthcertificatethatincludesmaternalmorbidityfields.However,priorworkshowsthatthe qualityofthematernalmorbiditydatafrombirthcertificatesispooranddoesnotsufficientlyidentify cases.3,7 Weconductedanupdateddata-quality assessmentofspecificmaternalmorbiditymeasures availableonthebirthcertificateandexamined
andJijiElizabethMathew, MS
OBJECTIVE: Toevaluatetheefficacyofantenatalcorticosteroidsinreducingneonatalrespiratorycomplicationswhenadministeredtothoseatriskofpreterm deliverybetween34and366/7weeksofgestation. METHODS: Thiswasasingle-center,triple-blind,randomized,placebo-controlledtrialinsouthernIndiaenrolling pregnantparticipantsatriskofpretermdeliverybetween 34and366/7weeksofgestation.Computer-generated blockrandomizationwasusedwithparticipantsrandom-
Seerelatededitorialonpage465.
FromtheDepartmentofPopulation,FamilyandReproductiveHealth,Johns HopkinsBloombergSchoolofPublicHealth,Baltimore,Maryland;the DepartmentofPediatrics,ChildrensHospitalofPhiladelphia,andtheLeonard DavisInstituteofHealthEconomics,WhartonSchool,UniversityofPennsylvania,Philadelphia,Pennsylvania;theHealthEconomicsResourceCenter,VeteransAffairsPaloAltoHealthcareSystem,MenloPark,andtheDepartmentof PediatricsandtheDepartmentofObstetricsandGynecology,StanfordUniversity SchoolofMedicine,Stanford,California;andtheDivisionofHealthPolicyand Management,UniversityofMinnesotaSchoolofPublicHealth,Minneapolis, Minnesota.FundingforthisworkwasprovidedinpartbytheNationalInstitutesofHealth EuniceKennedyShriverNationalInstituteofChildHealthandHuman Development(grantsR01HD084819toDrs.PhibbsandLorchand R01HD099197toDr.Phibbs)andtheNationalInstituteonMinorityHealth andHealthDisparities(grant[U54MD000214toDr.Gemmill]).Thiswork waspartlyfundedbytheNationalInstituteofNursingResearch(grants NR020335andNR017020toDr.Carmichael). Eachauthorhasconfirmedcompliancewiththejournalsrequirementsfor authorship.Correspondingauthor:AlisonGemmill,PhD,DepartmentofPopulation, FamilyandReproductiveHealth,JohnsHopkinsBloombergSchoolofPublic Health,Baltimore,MD;agemmill@jhu.edu. FinancialDisclosure Theauthorsdidnotreportanypotentialconflictsofinterest. ©2024bytheAmericanCollegeofObstetriciansandGynecologists.Published byWoltersKluwerHealth,Inc.Allrightsreserved. ISSN:0029-7844/24
FromtheDivisionofMaternalFetalMedicine,SanGabrielValleyPerinatal MedicalGroup,PomonaValleyHospitalMedicalCenter,Pomona,California. Eachauthorhasconfirmedcompliancewiththejournalsrequirementsfor authorship. Correspondingauthor:RichardM.Burwick,MD,MPH,MaternalFetal Medicine,SanGabrielValleyPerinatalMedicalGroup,PomonaValley HospitalMedicalCenter,Pomona,CA;richardburwick@gmail.com. FinancialDisclosure RichardBurwickservesonadvisoryboardsforComancheBiopharma,Roche Diagnostics,andUCBBiosciencesandservesonadvisoryboardsandthespeakers bureauforAlexion,AstraZenecaRareDisease.Theotherauthordidnotreport anypotentialconflictsofinterest. ©2024bytheAmericanCollegeofObstetriciansandGynecologists.Published byWoltersKluwerHealth,Inc.Allrightsreserved. ISSN:0029-7844/24
VOL.143,NO.4,APRIL2024
FromtheDepartmentsofObstetricsandGynecology,Neonatology,andBiostatistics,ChristianMedicalCollege,Vellore,India;andNewbornServices,Joan KirnerWomen sandChildren satSunshineHospital,St.Albans,andthe DepartmentofObstetricsandGynecology,UniversityofMelbourne,Melbourne, Victoria,Australia. TheIRBofChristianMedicalCollege,Vellore,providedfundsthatwereusedtoward employmentoftheresearchassistantandforpurchasingandpackagingthestudydrug. TheIRBhadnoroleinthestudydesign;collection,analysis,andinterpretationof data;writingofthereport;orthedecisiontosubmitthereportforpublication. Theauthorsthankalltheparticipantsandtheirneonatesforbeingapartofourtrial. TheythanktheIRBofChristianMedicalCollege,Vellore,forthefinancialassistance toconductthisrandomizedtrial.SpecialthanksgotoMrs.KumariSekar,who relentlesslyworkedtoscreenindividuals,coordinatedrecruitment,obtainedandmaintainedtheconsentforms,andfilledtheproformas,andforeffortlesslyensuringthat dataentrywasuptodate.TheauthorsalsothankDr.AnnaduraiSubramanian,head ofmanufacturing,DivisionofPharmacy,fordiligentlyworking,alongwithhisstaff, toprovidethestudydrugontime,andDr. support,andguidanceindataanalysisandinterpretation.JohnIdikullaforhisoversight,advice, Eachauthorhasconfirmedcompliancewiththejournal srequirementsfor authorship. Correspondingauthor:HildaYenuberi,DepartmentofObstetricsandGynecology,ChristianMedicalCollege,TamilNadu,India;hildagrace@gmail.com. FinancialDisclosure Theauthorsdidnotreportanypotentialconflictsofinterest. ©2024bytheAmericanCollegeofObstetriciansandGynecologists.Published byWoltersKluwerHealth,Inc.Allrightsreserved. ISSN:0029-7844/24
©2024bytheAmericanCollegeofObstetricians andGynecologists.PublishedbyWoltersKluwerHealth,Inc. Unauthorizedreproductionofthisarticleisprohibited.VOL.143,NO.3,MARCH2024
ValidityofBirthCertificateDataCompared WithHospitalDischargeDatainReporting MaternalMorbidityandDisparitiesAlisonGemmill, PhD,MollyPassarella, MS,CiaranS.Phibbs, PhD,ElliottK.Main, MD ScottA.Lorch,MD,KatyB.Kozhimannil,PhD,SuzanL.Carmichael,PhD,andStephanieA.Leonard,PhD
izedtoeitheronecourseofintramuscularbetamethasone orplacebo.Theprimaryoutcomewasacompositeof treatmentfor respiratorydistress intheneonate,definedas needforoxygenorcontinuouspositiveairwaypressureor mechanicalventilationforatleast2hoursinthefirst72 hoursoflife.Neonatalsecondaryoutcomesweretransient tachypneaofthenewborn,respiratorydistresssyndrome, necrotizingenterocolitis,sepsis,hyperbilirubinemia,hypoglycemia,stillbirth,andearlyneonataldeath;maternalsecondaryoutcomeswerechorioamnionitis,postpartum hemorrhage,puerperalfever,andlengthofhospitalization. Allanalyseswerebasedonintentiontotreat.Asamplesize of1,200wasplannedwith80%powertodetecta30% reductioninratesofrespiratorydistress.Afteraplanned interimanalysis,enrollmentwasstoppedforfutility.
FromtheDepartmentofPopulation,FamilyandReproductiveHealth,Johns HopkinsBloombergSchoolofPublicHealth,Baltimore,Maryland;the DepartmentofPediatrics,ChildrensHospitalofPhiladelphia,andtheLeonard DavisInstituteofHealthEconomics,WhartonSchool,UniversityofPennsylvania,Philadelphia,Pennsylvania;theHealthEconomicsResourceCenter,VeteransAffairsPaloAltoHealthcareSystem,MenloPark,andtheDepartmentof PediatricsandtheDepartmentofObstetricsandGynecology,StanfordUniversity SchoolofMedicine,Stanford,California;andtheDivisionofHealthPolicyand Management,UniversityofMinnesotaSchoolofPublicHealth,Minneapolis, Minnesota. FundingforthisworkwasprovidedinpartbytheNationalInstitutesofHealths EuniceKennedyShriver NationalInstituteofChildHealthandHuman Development(grantsR01HD084819toDrs.PhibbsandLorchand R01HD099197toDr.Phibbs)andtheNationalInstituteonMinorityHealth andHealthDisparities(grant[U54MD000214toDr.Gemmill]).Thiswork waspartlyfundedbytheNationalInstituteofNursingResearch(grants NR020335andNR017020toDr.Carmichael). Eachauthorhasconfirmedcompliancewiththejournalsrequirementsfor authorship. Correspondingauthor:AlisonGemmill,PhD,DepartmentofPopulation, FamilyandReproductiveHealth,JohnsHopkinsBloombergSchoolofPublic Health,Baltimore,MD;agemmill@jhu.edu. FinancialDisclosure Theauthorsdidnotreportanypotentialconflictsofinterest. ©2024bytheAmericanCollegeofObstetriciansandGynecologists.Published byWoltersKluwerHealth,Inc.Allrightsreserved. ISSN:0029-7844/24
Agrowingnumberofstudiesareusingbirthcertificate data,despitedata-qualityconcerns,tostudymaternal morbidityandassociateddisparities.Weexamined whetherconclusionsabouttheincidenceofmaternal morbidity,includingBlack–Whitedisparities,differ betweenbirthcertificatedataandhospitalizationdata. Usinglinkedbirthcertificateandhospitalizationdata fromCaliforniaandMichiganfor2018(N5543,469), wefoundthatmaternalmorbiditymeasuresusing birthcertificatedataalonearesubstantiallyunderreportedandhavepoorvalidity.Furthermore,the degreeofunderreportinginbirthcertificatedatadiffersbetweenBlackandWhiteindividualsandresults
RESULTS: FromMarch2020toAugust2022,847participantswererecruited,with423participantsrandomized tobetamethasoneand424participantsrandomizedto placebo.Therewere22individualslosttofollow-up. Therewasnostatisticallysignificantdifferenceinthe primaryoutcome(betamethasone4.9%vsplacebo4.8%, relativerisk1.03,95%CI,0.57–1.84,numberneededto treat786).Therewerenostatisticallysignificantdifferencesinsecondaryneonatalormaternaloutcomes. CONCLUSION: Betamethasoneadministeredinthe late-pretermperiodtothoseatriskforpretermdelivery didnotreducetheneedfortreatmentofneonatal respiratorydistress.
OBSTETRICS&GYNECOLOGY
©2024bytheAmericanCollegeofObstetricians andGynecologists.PublishedbyWoltersKluwerHealth,Inc. Unauthorizedreproductionofthisarticleisprohibited.
©2024bytheAmericanCollegeofObstetricians andGynecologists.PublishedbyWoltersKluwerHealth,Inc. Unauthorizedreproductionofthisarticleisprohibited.
Guidance downloaded more than 570,000 times in 2024
CLINICALTRIALREGISTRATION: ClinicalTrialsRegistry ofIndia,CTRI/2019/09/021321. (ObstetGynecol2024;143:468–74) DOI:10.1097/AOG.0000000000005520 A ntenatalcorticosteroidsarethestandardofcare forpretermdeliveriesbefore34weeksofgesta-
©2024bytheAmericanCollegeofObstetricians andGynecologists.PublishedbyWoltersKluwerHealth,Inc. Unauthorizedreproductionofthisarticleisprohibited. VOL.143,NO.3,MARCH2024
inerroneousinferencesaboutdisparities.Overall, Black–Whitedisparitiesweremoremodestinthebirth certificatedatacomparedwiththehospitalization data.Birthcertificatedataaloneareinadequatefor studiesofmaternalmorbidityandassociatedracial disparities. (ObstetGynecol2024;143:459–62) DOI:10.1097/AOG.0000000000005497Preventingseverematernalmorbidity(SMM)and andpolicyinterest.associateddisparitieshasgarneredintenseclinical TheCentersforDiseaseControl andPrevention(CDC)identifiesSMMinadministrativedatabasedonatleast1of21indicatorsofpotentiallylife-threateningeventsoccurringduringlabor anddelivery.2 Theseindicatorsareidentifiedusing InternationalClassificationofDiseasesdiagnosisand procedurecodes.3 Nationalhospitalizationdatawith thesecodes(eg,NationalInpatientSample)canbe cost-prohibitivetoaccess,arenotreadilyavailableat thestatelevel,andhaveincompleteinformationon raceandethnicity.Birthcertificatedata,bycontrast, arefreelyavailable,includenearlyallbirthsinthe nicity.UnitedStates,andcontainself-reportedraceandethAnincreasingnumberofstudiespublishedin high-impactjournalsaremeasuringmaternalmorbidityusingonlydatafromthebirthcertificate,4–becauseallstates(since2014)haveimplementeda6 revisedbirthcertificatethatincludesmaternalmorbidityfields.However,priorworkshowsthatthe qualityofthematernalmorbiditydatafrombirthcercases.tificatesispooranddoesnotsufficientlyidentify 3,7 Weconductedanupdateddata-quality assessmentofspecificmaternalmorbiditymeasures availableonthebirthcertificateandexamined
OBSTETRICS&GYNECOLOGY 459
ACOG is the most trusted source for reliable, timely clinical guidance for ob-gyns and the public that is based on the best available evidence. More than 10 active standing committees and expert workgroups prioritize clinical topics, review current evidence, and develop clinical recommendations, all of which are published in ACOG’s leading peer-reviewed journal, Obstetrics & Gynecology, also known as the Green Journal. Our guidance was downloaded more than 570,000 times in 2024. More than 125 literature searches and 12,000 manuscripts were downloaded to support development of guidance.
ACOG’s Clinical Practice Guidelines provide clinical management recommendations that are developed through assessment of the benefits and harms of care options based on systematic review of the evidence.
Clinical Practice Updates are brief statements that communicate a focused update of a section of clinical guidance included in an existing ACOG document. Clinical Practice Updates are published online only in Obstetrics & Gynecology.
“Biomarker Prediction of Preeclampsia With Severe Features”
“Screening for Gestational and Pregestational Diabetes Mellitus in Pregnancy and Postpartum”
“Paternal and Fetal Genotyping in the Management of Alloimmunization in Pregnancy”
“Update on Criteria for Suspected Diagnosis of Intraamniotic Infection”
“Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation”
“Age to Initiate Breast Cancer Screening”
“Management of Full-Term Nulliparous Individuals Without a Medical Indication for Delivery”
Practice Advisories are issued in response to emergent clinical issues that require immediate attention. They provide clinical guidance and are reviewed periodically for reaffirmation, revision, or incorporation into other ACOG guidelines. These advisories are designed to aid clinicians in providing obstetric and gynecologic care, and their use is voluntary.
• “Zuranolone for Treatment of Postpartum Depression”
• “Rho(D) Immune Globulin Shortages”
• “First Over-the-Counter Daily Contraceptive Pill Released”
• “Management of Obstetric–Gynecologic Patients During a Measles Outbreak”
• “Screening for Syphilis in Pregnancy”
• “Update on Oropouche Virus and Potential Effects on Pregnancy”
• “Increase in Human Parvovirus B19 Activity in the United States”
• “Intravenous Fluid Shortage”
Clinical Consensus documents provide recommendations on focused clinical issues based on a careful examination of available scientific data and supplemented with expert opinion when the evidence is limited. In 2024, ACOG introduced “The Use of Cannabis Products for the Management of Pain Associated With Gynecologic Conditions.” This document was determined to be a necessary resource based on the growing amount of information in scientific literature and public discourse about use of cannabinoids to manage pain.
Committee Statements address issues related to the practice of obstetrics and gynecology, such as ethics and opportunities for advancing equity.
DOCUMENTS INTRODUCED IN 2024 INCLUDE …
Influenza in Pregnancy: Prevention and Treatment
Permanent Contraception: Ethical Issues and Considerations
Ethical Considerations for Increasing Inclusivity in Research Participants
Racial and Ethnic Inequities in Obstetrics and Gynecology
Addressing Social and Structural Determinants of Health in the Delivery of Reproductive Health Care
Health Care for Women and Gender-Diverse Active-Duty and Reserve Uniformed Service Members and Veterans
Self-Managed Abortion
ACOG is a leading voice in important national and international proceedings related to clinical guidance for obstetric and gynecologic care. ACOG partners with national subspecialty obstetrics and gynecology organizations such as the Society for Maternal-Fetal Medicine, the Society of Family Planning, the Society of Gynecologic Oncology, the American Urogynecologic Society, the American Society for Colposcopy and Cervical Pathology, and the American Society for Reproductive Medicine to ensure that our guidance is aligned and applicable to a broad range of physicians. Additionally, ACOG has collaborated with other organizations, including the American College of Surgeons, the American College of Radiology, the American Cancer Society, and the National Commission on Correctional Health Care, to address health issues important to our members and their patients.
ACOG QUALITY AND SAFETY INITIATIVES DELEGATION
The ACOG Quality and Safety Initiatives Delegation, comprised of representatives from every District, met quarterly to share bidirectional updates on patient safety and quality improvement work at the ACOG national office and in each District and Section. During the summer 2024 meeting, which was held as a shared meeting with the ACOG Diversity, Equity, and Inclusion (DEI) Delegation, speakers provided updates on integration of equity into quality improvement.
In 2024, the delegation developed and authored Committee Statement: Quality Improvement Strategies for Safe Reduction of Primary Cesarean Birth, addressing nulliparous, term, singleton, and vertex cesarean birth. The Committee Statement will be published in Obstetrics & Gynecology in May 2025.
Voluntary Review of Quality of Care is a confidential, voluntary, consultive peer review series that ACOG offers to health care institutions. In 2024 …
18 The two most popular clinical studies selected for review:
3 540
42%
Cesarean birth for nonreassuring or indeterminant heart rate (of charts)
36% Induction of labor (of charts)
40 hospital site visits were conducted health systems, comprising 14 sites, were reviewed hospital charts were reviewed review team members participated in visits
2
Voluntary Review of Quality of Care program managers joined ACOG
In March 2024, ACOG’s Indigenous Health program cohosted the eighth Annual Indigenous Women’s Health Meeting, which brought in more than 250 attendees dedicated to serving Indigenous and Native communities across the United States and Canada.
The ACOG Committee on Indigenous Health, supported by program staff, completed site visits at three Indian Health Service Great Plains Area facilities in June 2024: Eagle Butte Hospital, Pine Ridge Hospital, and Rosebud Hospital, which primarily serve the Lakota and Cheyenne River Sioux Tribes. Sites were reviewed for the quality and safety of provided ob-gyn care. Findings from the site visits were shared with Indian Health Service and area leadership.
Funded by HRSA, the Alliance for Innovation on Maternal Health (AIM) Technical Assistance Center provides comprehensive, high-impact technical assistance in the form of learning collaboratives, peer learning opportunities, skills training sessions, one-on-one coaching, mentoring, and individual consultations to all entities implementing AIM patient safety bundles in the United States. The Technical Assistance Center helps states and entities engage birthing facilities to participate in AIM, supports education for health care professionals on AIM resources, strengthens quality improvement processes, and addresses participation and implementation barriers associated with AIM patient safety bundles.
22,298
51
2,069
75%
80+
times the patient safety bundle learning modules have been completed as of December 2024
participating bodies: 49 states, the District of Columbia, and Puerto Rico
participating birthing facilities
of participating birthing facilities working with AIM state and jurisdiction teams
languages available for the Urgent Maternal Warning Signs patient resources
MATERNAL MORTALITY
To reduce preventable maternal mortality, ACOG collaborates with CDC and a robust network of partner organizations to build the capacity of obstetric care clinicians and those practitioners who practice outside the obstetric setting to improve the health outcomes of pregnant and postpartum people through training, data sharing, and development of materials.
To reduce the burden of vaccine-preventable diseases among those pregnant and recently pregnant, this program focuses on increasing Tdap, influenza, COVID-19, and RSV immunization rates by collaborating with organizations comprised of clinicians who provide clinical care. Initiatives under this program include ...
Overseeing the ACOG-led Maternal Immunization Task Force in collaboration with the American Academy of Family Physicians; American College of Nurse-Midwives; Association of Women’s Health, Obstetric and Neonatal Nurses; National Association of Nurse Practitioners in Women’s Health; and Society for Maternal-Fetal Medicine
Hosting an annual Maternal Immunization Summit meeting of stakeholders working to improve maternal immunization rates
Evaluating ACOG’s maternal immunization resources through surveys and focus groups of pregnant and recently pregnant people
Developing a video series encouraging pregnant people to get recommended vaccines during pregnancy, which received more than 600,000 plays across all videos
Attending national partner meetings to promote ACOG resources and foster collaboration with obstetric care professional organizations
Overseeing ACOG’s Immunization Champion Award, given to 27 champions in the past six years
ACOG’s Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group
for practitioners in emergency department, prehospital care, and urgent care settings to enhance readiness to identify and manage patients with obstetric emergencies during pregnancy and the postpartum period
Disseminated state maternal mortality data and actions to eliminate preventable maternal deaths and hosted the annual ACOG/CDC Maternal Mortality Prevention Meeting during ACOG’s ACSM
Disseminated maternal mortality prevention data at 12 meetings and conferences, including at ACOG/CDC Maternal Mortality Prevention Meetings, and on ACOG’s website at acog.org/ obemergencies
An Immunization Champion is someone who understands the power of vaccines to save and to improve lives and focuses on approaches to reach and vaccinate underserved communities. I’m an Immunization Champion. Are you?
—Naima Joseph, MD, MPH, FACOG, 2024 Immunization Champion
This program disseminates knowledge about the prevention and early diagnosis of early onset breast cancer and gynecologic cancers.
HIGHLIGHTS IN 2024 INCLUDE …
Series of five free, CME-accredited online eModule courses
Six journal articles published in Obstetrics & Gynecology
Early onset breast cancer campaign: Don’t Lump Your Patients Together
Uterine, ovarian, and lower anogenital tract cancers campaign: Are You Seeing the Full Picture?
Series of 11 MicroRounds, which are short, educational video presentations tackling important clinical topics and highlighting research gaps in early onset breast and gynecologic cancers
This funding from CDC’s National Center on Birth Defects and Developmental Disabilities and Division of Reproductive Health supports ACOG’s efforts to improve pregnancy outcomes by preventing infections and reducing the impact of emerging threats.
IN 2024, ACOG FOCUSED ON …
Promoting our popular Labor of Love podcast, which was downloaded more than 14,000 times in its three seasons
Developing Compassionate Conversations webinars focused on obstetric care
Developing patient education videos on preventing infections during pregnancy and maternal immunization
DOCUMENTS PUBLISHED IN 2024 INCLUDE ...
FAQs: Cytomegalovirus (CMV) in Pregnancy
Syphilis Testing Algorithm
FAQs: Maternal RSV Vaccination
Seven Things to Share with Your Patients about the Maternal RSV Vaccine
I’m thankful and honored to have this podcast as a platform to share our challenges and our victories, learn from each other, inspire each other to care for our patients, care for each other, cheer for ourselves, and hopefully make a better tomorrow.
—
Veronica Pimentel, MD, MS, FACOG, ob-gyn and host of Labor of Love
THE WOMEN’S PREVENTIVE SERVICES INITIATIVE (WPSI), AN ACOG FOUNDATION PROGRAM FUNDED BY HRSA, ACHIEVED THE FOLLOWING KEY SUCCESSES IN 2024 ...
Recommended Breast Cancer Screening for Women at Average Risk, which HRSA accepted. These recommendations will eliminate significant costs associated with tests required to complete the breast cancer screening clinical pathway. This updated recommendation will affect millions of women, given that up to 10% of women require follow-up after initial screening.
Recommended Patient Navigation Services for Breast and Cervical Cancer Screening, which HRSA accepted and which will guide patients through their clinical journey to address language, literacy, disability, and socioeconomic barriers to cancer screening. By providing comprehensive support, this initiative aims to ensure equitable access to vital cancer screening services.
Launched the inaugural WPSI CME course, open to all clinical professionals seeking CME credits. It offers a comprehensive overview of WPSI recommendations and methodology.
Launched a pilot project testing the implementation of two crucial groundbreaking WPSI recommendations: screening for intimate partner violence and anxiety. This initiative spans 12 urban, rural, and federally qualified health centers, including ambulatory care centers.
In 2024, ACOG developed a new video for the How I Practice video series titled Screening for Diabetes In and After Pregnancy and shared it with our network of
62,000 members members and other stakeholders.
To support its members and their work, ACOG provides policy analysis and advocacy for coverage and payment policies from private payers, commercial payers, and public payers such as Medicare and Medicaid. Additionally, ACOG publishes educational resources such as webinars, podcasts, the annual Coding Manual and quick reference guides, and the Payment Advocacy & Policy Portal to meet members’ needs.
In 2024, ACOG and its members submitted 41 letters to federal and state policy makers across CMS, FCC, and HHS covering data privacy, prior authorization, payment, health equity, preventive services, and coverage and eligibility.
ACOG’s Payment Advocacy & Policy Portal makes it possible for members to submit coding questions to our coding and policy experts. In 2024, members submitted 1,184 tickets, an increase of 20.45% from 2023. Top questions received from members addressed global billing in obstetrics, fetal nonstress test billing, delivery with postpartum care only, membrane stripping, and prolonged OB visits.
3,333
total users
ACOG’s Payment in Practice course, 2024 OB/GYN Coding Manual, and coding quick reference guides help support ob-gyns through coding and best practices for reimbursement. In July of 2024, ACOG released the first of three courses in our new Payment in Practice series.
811
new active users in 2024
91.4% satisfaction rate for members who asked insurance and coding questions
ACOG’s Health and Payment Policy team also hosts Compassionate Conversations webinars—live panel discussions that ACOG members lead regarding difficult conversations they face in practice—for ACOG members and the broader public. In 2024, ACOG held seven Compassionate Conversations on topics such as stillbirth, maternal mental health, and cytomegalovirus, among others. The sessions attracted 560 live viewers. Compassionate Conversations also has a companion podcast series on maternal mental health.
ACOG’s Committee on Health Economics and Coding works in tandem with the Health and Payment Policy team to advocate for adequate physician reimbursement through work with the AMA and payers targeting payment methodologies. The committee performed a payment evaluation that was published in the February online issue of the Green Journal.
15,778 article reviews
ACOG’s commitment to science and evidence-based medicine extends to the policy-making arena, where our legislative and regulatory influence continues to grow in the face of mounting political interference in the practice of medicine. Our advocacy activities are wide-ranging and include lobbying on Capitol Hill, with federal agencies, and in statehouses and governors’ offices across the United States. ACOG is also a leader within the AMA and hosts a number of policy-honing events, such as the Congressional Leadership Conference and State Legislative Roundtable.
ACOG’S STRATEGIC ADVOCACY CONTINUES TO ADVANCE BIPARTISAN PRIORITIES CONSISTENT WITH OUR COMMITMENT TO POLICY ACTION. ACTIVITIES IN 2024 INCLUDE …
Introducing and advocating for dozens of bills to improve maternal and infant health outcomes, including the bipartisan Rural Obstetrics Readiness Act and Black Maternal Health Momnibus Act
Celebrating the Preventing Maternal Deaths Reauthorization Act passing the House and the enactment of the Maternal and Child Health Stillbirth Prevention Act
Collaborating with key congressional committees to inform public hearings and development of reports on the impact of the Dobbs decision on physicians and ob-gyn residents. ACOG’s efforts, including facilitating key connections between congressional staff and ACOG members, resulted in three published congressional reports:
» “It Will Only Get Worse”: How the Supreme Court’s Dobbs Decision Will Decimate Reproductive Health Care for Generations
» Two Years Post-Dobbs: The Nationwide Impacts of Abortion Bans
» Practicing Amid “a Minefield”: Emergency Reproductive Health Care Post-Dobbs
Advocating for a long-term fix to the flawed Medicare physician payment system
Providing technical assistance to lawmakers seeking to introduce legislation to protect, restore, and improve access to reproductive health care—including abortion and IVF—to ensure that legislation is consistent with medical evidence but does not legislate the practice of medicine
In 2024, ACOG filed 22 briefs in state and federal courts across the United States defending access to essential reproductive health care; opposing the criminalization of evidence-based medicine and the prosecution of patients based on the outcomes of their pregnancies; and supporting the anti-discrimination provisions in the Affordable Care Act and coverage of preventative care services, including contraception.
In 2024, ACOG continued to serve as the authority on policies affecting all those seeking obstetric and gynecologic care. Our 14-member delegation to the AMA is a powerful and respected voice, providing critical on-the-ground perspectives of ob-gyns and their patients.
ACOG DELEGATION MEMBERS SHARED POWERFUL TESTIMONIES WITH THE AMA HOUSE THAT PROPELLED ACCOMPLISHMENTS AT THE JUNE AND NOVEMBER 2024 MEETINGS, INCLUDING NEW AMA POLICIES THAT …
• Support separate payments for services not accounted for in the valuation of maternity global codes and oppose inappropriate bundling of related services
• Support increased payer accountability for harm caused by delay or denial of prior authorization
• Support physicians and medical students who experience doxing, or publishing of private or identifying information with malicious intent
• Update AMA policy on HPV-associated cancer prevention to support strategies to increase vaccine availability and accessibility
• Support insurance coverage for infertility diagnosis and treatment and oppose policies that could criminalize IVF or otherwise confer personhood upon gametes or embryos
In March 2024, more than 700 ob-gyns convened in Washington, D.C., for the annual Congressional Leadership Conference (CLC) to hone their advocacy skills, build relationships with members of Congress, and network with colleagues. During meetings with legislators, attendees advocated for legislation to support maternal mortality review committees (MMRCs), championed a long-term solution to stop Medicare physician payment cuts and ensure sustainability of physician practice, and shared the importance of continued access to IVF.
In a survey following the event, the vast majority of respondents (95%) agreed or strongly agreed that the CLC contributes to a positive ACOG member experience.
Our members enthusiastically endorse the experience!
ACOG’s State Legislative Advocacy team works with our Sections and Districts to help promote state priorities, uplift state legislative agendas, and support lobbyists working on our behalf in all ACOG Districts and most Sections.
Authoring an opposition letter for Idaho regarding HR 381, which would have amended existing law to redesignate the terms “fetus” and “stillborn fetus” to “preborn child” and “stillborn child,” respectively. The bill failed in the House committee.
As a new Junior Fellow member, I didn’t know how I could be involved in ACOG or advocacy. The CLC gave me tools for both.
Advocacy is a huge part of why I love obstetrics and gynecology so much, so having our national organization prioritize advocacy is very important to me.
[CLC was] such an inspiring experience [and] provided me with a needed reminder of why I went into medicine.
Authoring a support letter for the Alaska Section regarding HR 17, which would require insurance companies to cover prescription contraceptives without a copayment and to retroactively cover prescriptions in certain circumstances. HR 17 passed both chambers and was vetoed by the governor.
Authoring critical comments on the Texas Medical Board’s proposed regulations clarifying medical exceptions to the abortion ban
Presenting to and collaborating with ACOG Districts on issues related to contraception legislation, Vot-ER voter registration drives, doula reimbursement, funding, resources for “model” bills, and more
At the 2024 State Legislative Roundtable in Minneapolis, Minnesota, 118 attendees representing District and Section legislative chairs from 45 states and Washington, D.C., gathered to hear experts interpret the complex political landscape and participate in panels and discussions focused on current and emerging legislative issues affecting obstetric and gynecologic care, increasing political engagement among ob-gyns, institutional advocacy, IVF, misinformation, and midwifery.
In New York and Colorado, ACOG endorsed successful ballot initiatives on abortion. While ACOG did not endorse the ballot initiatives in Nebraska, Florida, Arkansas, or Arizona, we worked with ob-gyns in those states to develop materials that uplifted their experiences operating under abortion restrictions. These stories and experiences have the power to make change and are vitally important.
IN 2024, ACOG PROVIDED ACTION ALERTS THAT URGED MEMBERS TO ...
Oppose HR 6085 and HR 6086 in Michigan, which would have increased the cap on noneconomic damages and expanded the types of damages recoverable in malpractice suits. Neither bill passed.
Oppose HR 195 in Alabama, which would have limited comprehensive sex education in schools. This bill ultimately did not pass.
Support a 12-month postpartum Medicaid extension in Wisconsin. This bill passed in the state senate but was not taken up in the assembly.
ACOG joined with the Democratic Attorneys General Association’s Reproductive Rights Working Group to collaborate with reproductive health, rights, and justice partners and staff from attorneys generals’ offices across the country.
Across public discourse and especially on social media, misinformation about obstetric and gynecologic care is proliferating. It appears in discussions across all areas of the specialty, including birth control, IVF, menopause, home birth, the HPV vaccine, and abortion. ACOG is promoting truth and evidence—and equipping our members to do the same with their patients and within their communities.
Sharing strategic content to reach across communications platforms to set the record straight about reproductive health care and all facets of obstetric and gynecologic care
Continuing to serve as an authoritative source for reporters who are seeking to separate misinformation from the truth
Beginning a first-of-its-kind digital advertising campaign funded by a grant from the ACOG Foundation that brought ACOG’s message—that abortion is health care—to online audiences in six abortion-restricted states. We specifically targeted states to directly counter harmful narratives. High levels of engagement proved that people are eager to learn the truth.
Developing member-facing social media tool kits with messaging and downloadable graphics to share as part of our digital advertising campaign urging viewers in select restricted states to know the facts about abortion
Spreading the truth and combating misinformation with rapid creation of evidence-based resources to arm our members and our partners with the facts. For example, Facts Are Important: Hormonal Birth Control rebuts the widespread mistruths that are spread to erode people’s confidence in safe and effective contraception.
53.8 million impressions
6.4 million viewers reached
Video: Abortion Is Essential Reproductive Health Care
With reproductive health care under attack, it’s critical that people have the facts they need to see through misinformation surrounding birth control. Get the information you need to empower yourself at ACOG’s Misinformation Hub.
In 2023, ACOG’s Equity Transformation team launched a series of live learning events focused on transforming our specialty to develop an equity and justice mindset. In 2024 we implemented the following:
With delegates from every District, the District DEI Delegation, now known as the Collective Action Advancing Respect and Equity Delegation, convened at the ACSM for a half-day strategic planning session to set new goals for the upcoming year of programming. Additionally, the delegation hosted a joint learning session with ACOG’s Quality and Safety Initiatives Delegation that focused on the intersections of patient quality and safety and health equity in ob-gyn health outcomes. The session highlighted the following data reporting efforts to track patient safety and promote strategies to advance maternal health equity through quality improvement and patient safety efforts:
Advances in patient safety have come from adverse event reporting data and quality measures that allow differential outcomes in practice to be visible so that they are properly addressed in care delivery
Stratifying data by race and ethnicity to help institutions identify inequities, inform action, and improve overall care, as bias and inequality may affect the process of safety event reporting when demographic data are not collected or analyzed
Engage and build relationships with community members in an effort to reduce mistrust from patient communities who have a history of being marginalized in health care or exploited by biomedical research. These relationships also reduced race- and gender-based bias against health care staff that could affect health care professionals’ perspectives on safety culture and patient safety reporting.
In June and November, virtual community events featured presenters Audra Robertson Meadows, MD, MPH, FACOG, and Serina Floyd, MD, MSPH, FACOG. Dr. Robertson Meadows spoke about why maternal health equity is fundamental to quality and how perinatal quality improvement efforts provide opportunities to optimize care, prevent maternal morbidity, and promote equity. In a session focused on reproductive justice in clinical practice, Dr. Floyd spoke about the definition of reproductive justice, reproductive injustices in our past and in our present, and how ob-gyns can apply a reproductive justice framework to the work they do.
Betsey, Lucy, and Anarcha were enslaved Black women who were leased to the gynecologist J. Marion Sims so that he could perform experimental procedures on them in front of witnesses without anesthesia. Every year on February 28 and March 1, the dates that bridge Black History Month and Women’s History Month, ACOG formally acknowledges the exploitation of enslaved women’s bodies and the contributions to obstetric and gynecologic knowledge that they were forced to make.
As part of the 2024 observance, ACOG members Brownsyne Tucker-Edmonds, MD, MPH, MS, FACOG; Omar M. Young, MD, FACOG; and Arthurine Zakama, MD, FACOG, participated in a roundtable discussion moderated by Michelle Owens, MD, MS, FACOG, titled The Importance of Mentorship in Medicine: Why Diverse Mentorship Matters. These experts from different stages in their careers shared their experiences about mentorship in clinical practice and across the career life span. They also discussed how mentorship supports the recruitment and retention of a diverse workforce and why diverse perspectives lead to better health outcomes. The discussion was broadcast to 300 attendees at the CREOG & APGO Annual Meeting.
IN 2024, ACOG INTRODUCED SEVERAL NEW PRODUCTS AND PUBLICATIONS DESIGNED TO MEET THE DIVERSE NEEDS OF OUR COMMUNITY, INCLUDING ...
The 2024 Coding On Demand and Payment in Practice online courses, offering convenient access to essential coding expertise
Payment in Practice: Foundations in Coding, which provides new physicians with essential knowledge in medical billing and coding for obstetric and gynecologic services through 17 interactive videos, realworld scenarios, and regular assessments
The 2024 OB/GYN Coding Manual: Components of Correct Coding, an indispensable reference for precise coding practices
In 2024, ACOG launched O&G Open, an online open-access journal that features peer-reviewed articles on a range of translational, clinical, and scientific topics pertaining to obstetrics, gynecology, and associated disciplines. Complementing Obstetrics & Gynecology, ACOG’s monthly leading print journal, this online publication is designed for obstetricians, gynecologists, reproductive endocrinologists, maternal–fetal medicine specialists, nurses, and other health care professionals involved in associated disciplines. To learn more, scan the QR code to visit the O&G Open site.
Obstetrics & Gynecology, also known as the Green Journal, continues to be the leading peer-reviewed journal in its field. Since 1953, ACOG has provided readers with articles on premier clinical research. Jason D. Wright, MD, FACOG, an internationally recognized expert in the treatment of gynecologic cancers and surgery, serves as editor in chief.
• ACOG Clinical Practice Guideline 8: “First and Second Stage Labor Management”
ACOG Committee on Clinical Practice Guidelines–Obstetrics in collaboration with Alison G. Cahill, MD, MSCI, FACOG; Nandini Raghuraman, MD, MSCI, FACOG; and Manisha Gandhi, MD, FACOG; with consultation from Anjali J. Kaimal, MD, MAS, FACOG. The Society for Maternal-Fetal Medicine supports this document.
• “Late-Preterm Antenatal Steroids for Reduction of Neonatal Respiratory Complications: A Randomized Controlled Trial”
Hilda Yenuberi, MD; Benjamin Ross, MD, Richa Sasmita Tirkey, MS; Santosh Joseph Benjamin, MS; Swati Rathore, MS; Reka Karuppusami, MSc; Aadarsh Lal, MSc; Niranjan Thomas, MD, FRACP; and Jiji Elizabeth Mathew, MS
• “Angiogenic Biomarkers in Preeclampsia”
Richard M. Burwick, MD, MPH, FACOG; and M. Hellen Rodriguez, MD
• ACOG Committee Statement 8: “Permanent Contraception: Ethical Issues and Considerations”
ACOG Committee on Ethics in collaboration with committee members Kavita Shah Arora, MD, MBE, MS, FACOG; Maryam Guiahi, MD, MSc, FACOG; and Lisa H. Harris, MD, PhD, FACOG
• “Validity of Birth Certificate Data Compared With Hospital Discharge Data in Reporting Maternal Morbidity and Disparities”
Alison Gemmill, PhD; Molly Passarella, MS; Ciaran S. Phibbs, PhD; Elliott K. Main, MD, FACOG; Scott A. Lorch, MD, MSCE; Katy B. Kozhimannil, PhD; Suzan L. Carmichael, PhD; and Stephanie A. Leonard, PhD
• Special Issue: “Diabetes in Pregnancy”
ACOG is helping to lead the way in transforming medical education by driving innovative educational initiatives and programming that provide educators with exceptional support and resources to ensure their learners are prepared to meet the moment.
IN 2024, ACOG SUPPORTED A NUMBER OF EDUCATIONAL INITIATIVES, INCLUDING …
The launch of ResidencyCAS, a powerful platform providing residency programs with the ability to holistically review applicants, facilitate exceptional alignment between applicants and programs, and contribute to the creation of a diverse workforce well suited to addressing the critical needs of the ob-gyn profession and patients
The launch of the CREOG Inclusive Excellence Program, a five-year approach to fostering inclusive excellence in U.S. obstetric and gynecologic residency programs consisting of a series of webinars and awards that support inclusive excellence curriculum development and implementation
Beginning the development of a national obstetric and gynecologic curriculum in conjunction with national cross-specialty discussions related to the movement toward competencybased medical education
The Patient-Centered Abortion Care Education Initiative, or PACE, an abortion care essentials curriculum available to all obstetrics and gynecology residents and residency programs across the United States. ACOG developed the curriculum in collaboration with CREOG, Innovating Education in Reproductive Health, and the Kenneth J. Ryan Residency Training Program in Abortion and Family Planning. This program is an online, module-based, self-study curriculum addressing the essentials of patient-centered abortion care education.
Total number of programs participating in year one:
292
(100% of U.S. residency programs)
95 residency programs are currently using the curriculum as of December 31, 2024, with a total of 455 residents enrolled. PACE by the Numbers
Total number of applicants: 2,431
Total number of ob-gyn residency applications received: 160,094
The CREOG In-Training Exam, a critical self-assessment for ob-gyn residents, was successfully administered to more than 6,000 residents across the country.
The CREOG Education Committee published several curricula on topics such as laparoscopic abdominal entry, neonatal circumcision, enhanced recovery in gynecology, and inequities in rural obstetric care.
ACOG IS PROUD TO HOST ANNUAL EDUCATIONAL EVENTS.
1
2
CREOG & APGO ANNUAL MEETING
This meeting brings together undergraduate and graduate medical educators to learn about the latest in educational practices and updates. In 2024, ACOG celebrated innovation with the theme Transforming Obstetrics and Gynecology Education: Brave Solutions for Enduring Challenges.
CREOG EDUCATIONAL RETREAT
The retreat provides a forum for ob-gyn residency program directors and managers to connect, share strategies and ideas, and discuss key topics affecting resident education. In 2024, the retreat focused on building resilience and finding joy as educators.
3
4
CREOG SCHOOL FOR RESIDENCY AND FELLOWSHIP PROGRAM DIRECTORS AND MANAGERS
The CREOG School is a hybrid course for new and seasoned program directors and managers led by experienced program director faculty. It addresses the fundamentals critical to a well-run residency program.
CREOG WORKSHOPS FOR RESIDENTS: PREPARING TO BE TEACHERS AND LEADERS
These workshops equip ob-gyn residents with the knowledge and skills necessary to serve as leaders and exemplary teachers for junior residents and medical students.
1,266 attendees
374 attendees (up 20% from 2023)
117 attendees
700 OB-GYNS FROM 11 COUNTRIES across three continents since its inception
96% OF RECENT CEFALO INSTITUTE PARTI CIPANTS have made changes to their communication and leadership approaches based on their experiences in the course
62% HAVE BEEN PROMOTED promoted, changed jobs, or taken on new leadership opportunities since completing the course
252 attendees
“The most amazing learning experience of my adult professional life!” —Cefalo Institute participant
ACOG’s premier educational conference, the ACSM, hosted more than 4,500 attendees in San Francisco, California, in May 2024. Over three days, participants attended 96 educational sessions, presented more than 350 abstracts, and enjoyed networking opportunities through receptions and the career fair.
New for 2024’s ACSM was the inclusion of four in-depth pre-meeting workshops focused on menopause and hands-on clinical emergency obstetrical procedures, which approximately 400 people attended.
ACOG is committed to educating patients and the public about obstetric and gynecologic conditions and health care. We develop and publish resources for patients and clinicians around the world.
ACOG’s patient website, acog.org/womens-health, serves as an essential resource hub offering current, evidence-based insights on a broad range of health topics. This reflects ACOG’s dedication to empowering patients to make informed health care choices on a variety of topics, such as birth control, menopause, prenatal testing, menstrual health, heart health, and vaccine recommendations. It also includes stories from real patients and ob-gyns. Accessible features include a user-friendly dictionary of obstetric and gynecologic health terms and downloadable infographics. All content is developed with ACOG guidance, reviewed by ACOG members, and crafted to align with health literacy standards, ensuring reliability and accessibility for all users.
IN 2024, ACOG EXPANDED THE ACOG EXPLAINS ANIMATED VIDEO SERIES, WITH FIVE NEW VIDEOS COVERING ...
Infertility tests and treatments
Preventing infections during pregnancy
Vaccines during pregnancy
Polycystic ovary syndrome
Birth control
These videos transform complex information into short, engaging, and easy-tounderstand animations for viewers.
million views, 8.9 million users, 11 million sessions
Top downloaded content included Hysterectomy, Polycystic Ovary Syndrome, Abnormal Cervical Cancer Screening, Uterine Fibroids, and Nutrition During Pregnancy
Trying to Get Pregnant? Here’s When to Have Sex To Shave or Not to Shave: An Ob-Gyn’s Guide to Pubic Hair Care Nutrition During Pregnancy
Bleeding After Menopause Could Be a Problem. Here’s What to Know
What You Should Know about Breakthrough Bleeding With Birth Control
This page provides detailed information on different birth control methods, their effectiveness, and potential side effects.
This page offers insights into managing menopause symptoms, including lifestyle changes and evidence-based medical treatments.
This page guides you through each trimester, addressing the changes and questions that arise. It provides answers and insights on what to expect during every stage of pregnancy.
Clinicians can refer patients to ACOG’s online materials, which are available in a variety of user-friendly formats. These include ...
New customizable health tools
Member-preferred infographics
Videos
Expert Views
FAQs
Ask ACOG items
These resources are based on ACOG’s clinical guidance and are free of charge. Additionally, clinicians may choose to purchase
the ACOG digital pamphlet and Fast Facts subscription to access more than 130 high-quality, evidence-based, illustrated digital pamphlets and Fast Facts handouts, available in both English and Spanish.
ACOG materials are continuously created and updated in response to ...
Evolving health concerns
Changes in clinical guidance, such as recommended duration of breastfeeding and guidance on viral hepatitis in pregnancy
Emerging health risks, such as RSV
Other identified areas of need
These resources cater to patients from puberty through menopause and beyond, addressing important issues such as health care for transgender and nonbinary adolescents; conditions and procedures that receive limited mainstream attention, such as screening for hemoglobinopathies; and everything in between.
For the fourth year in a row, ACOG observed Maternal Health Awareness Day. The 2024 theme was Access in Crisis, reflecting the ongoing challenges people face in accessing maternal and reproductive health care. It attracted record levels of international engagement from influential partners and stakeholders.
In the wake of the Dobbs v. Jackson Women’s Health Organization decision, people are increasingly unable to access needed abortion care, leaving them at risk of complications and
even death and further compounding existing challenges in access and disparities in outcomes. The maternal health crisis is felt most profoundly by Black and American Indian and Alaska Native people, whose maternal mortality rate is two to three times higher than that of white people, according to CDC data.
The live webinar, which featured then-ACOG President Verda J. Hicks, MD, FACOG, from Kansas; Margaret Chou, MD, FACOG, from Delaware; Charlene Collier, MD, MPH, MHS, FACOG, from Mississippi; Kylie Cooper, MD, FACOG, from Minnesota; Katherine Glaser, MD, FACOG, from Arizona; and Richard Todd Ivey, MD, FACOG, from Texas. The webinar also featured Allie Phillips, a patient from Tennessee who was unable to obtain an abortion in her home state after receiving a heartbreaking diagnosis during her 19th week of pregnancy.
More than
700 VIEWERS watched the live webinar.
Medical Students
11,600
Life Fellows and Fellows Senior Status
4,553
Associate and Educational Affiliate Members
5,268
Fellows
30,038
Junior Fellows
11,118
Female: 43,914
Male: 17,966
Not specified: 201
Prefer not to answer: 360
Nonbinary: 98
Prefer to self-describe: 15
Queer: 12
Transgender man: 8
Transgender woman: 3
United States: 60,019
Mexico: 491
Canada: 410
Other Countries: 1,657
In 2024, ACOG members came together for regional meetings throughout the United States to discuss and debate critical topics and provide educational opportunities for professionals involved in obstetric and gynecologic care.
Nurturing the Next Generation District I’s annual Virtual Residency Fair included 15 programs, 45 speakers, and more than 400 medical students.
At the 2024 Districts I, V & VI Annual District Meeting in Boston, Junior Fellow and Early-Career Fellow leadership organized an exciting day dubbed How to Be a Life-Long Learner, which featured …
Panels on finding the right residency program, fellowship program, and your niche
Hands-on skills workshops on manual vacuum aspiration, IUD placement, knot tying, and suturing
Interactive sessions on navigating professional challenges, networking, job hunting, business administration, and negotiating
Prioritizing Education and Advocacy
To create a community of support, learning, and mentorship,
Offered more than 200 leadership opportunities and delivered education to 550 individuals
Facilitated more than 500 engagements in direct and grassroots advocacy in support of policies that promote science, enhance access, prevent legislative interference, and strengthen the profession
Prevented dozens of harmful legislative mandates
Succeeded in voter approval of Prop 1, a ballot measure that protected reproductive health care access
Secured for a third time a veto of harmful legislation that would have significantly expanded liability exposure and cost
Equipped members with tools to advocate through a two-day Resident Advocacy Program
District II’s Safe Motherhood Initiative (SMI) offers ob-gyns and maternal health teams tools to reduce maternal mortality and address racial disparities in health outcomes. Building on AIM’s work, the SMI launched a cardiac bundle to provide implementation tools and resources. The SMI annual meeting provided a statewide forum to share best practices, foster collaboration, and develop solutions to improve health outcomes.
6 bundles created (hypertension, hemorrhage, cardiac, VTE, sepsis, MEWS)
3 sepsis Grand Rounds presentations held
5 cardiac Grand Rounds presentations held
42,331 visits to the SMI app
11,155 different users who accessed the app
941 total hours of engagement
Leading Day by Day
Each year, District III provides a recorded webinar online for members to use during local Maternal Health Awareness Day initiatives. In 2024 we featured a webinar by Adi Hirshberg, MD, and Kirstin Leitner, MD, FACOG, from the Hospital of the University of Pennsylvania.
Each year, District III brings together up to 250 residents and medical students to hear lectures, learn about ACOG, and participate in topical roundtables and hands-on simulations. Up to 20 residency programs are represented each year.
Panelists featured in the 2024 District III Maternal Health Awareness Day webinar
District IV officers presented at the PROGyn Sunshine Seminar 2024 in San Juan, Puerto Rico, where they spoke about industry updates and education and forged relationships with ACOG members from Puerto Rico.
At the first West Virginia Section Meeting in five years, District IV officers shared their clinical expertise and reengaged with the West Virginia Section.
Hosted the West Virginia Section Meeting
By integrating artistic expression with reflective dialogue, the Harmony Project offers a unique avenue for stress relief, fostering emotional wellness and camaraderie among health care professionals facing the relentless demands of their field. Beyond its immediate impact, the project advocates for a broader cultural shift, emphasizing the importance of holistic well-being and interconnectedness in health care settings. Through their involvement, participants contribute not only to a shared creative work but also to a vision of a more empathetic and resilient health care system where individual wellness and collective strength pave the way for enhanced patient care.
The District VI communications team established a social media footprint in 2024, enhancing member experience by communicating valuable information through graphics.
The District VI Junior Fellow Advisory Council continued to provide opportunities for the community to gather by hosting events. Events included a book club to discuss All in Her Head: The Truth and Lies Early Medicine Taught Us About Women’s Bodies and Why It Matters Today by Elizabeth Comen, the battle of the residency programs at the annual CREOG Jeopardy event, and the screening of the documentary The Fight for Black Lives .
In 2024, District VII committees hosted eight live webinars reaching more than 800 ACOG members and public health officials. Topics included tackling social media misinformation about contraception, raising awareness about how physicians can use social media to improve HPV vaccination rates, and practical measures that can be taken to improve maternal mortality.
At the 2024 District VII Annual District Meeting, the Diversity, Equity, and Inclusive Excellence Committee engaged members in a hands-on communication workshop titled Using the Power of Curiosity to Transform Difficult Conversations in Health Care.
The District VII HPV Vaccine Committee reel contest engaged physicians and residents to make Instagram reels, which have received more than 9,000 views since October 2024.
The Mexico Section reached 1,200 Instagram followers and 2,900 Facebook followers in 2024. The Section now has six medical student interest groups registered with ACOG.
District VIII’s annual summit, a three-hour virtual meeting with the state MMRC, included overviews from CDC and HHS. District members shared notes, made connections, and learned about MMRC findings across the various Sections. They also unpacked how MMRCs are turning findings into actions to prevent maternal mortality.
The Peer Support Program—launched in 2019 by Laurie Gregg, MD, FACOG; Mibhali Bhalala, MD, FACOG; and Marie Boller, MD, FACOG—provides a safe space for Fellows and Junior Fellows to share experiences and support each other, thereby addressing burnout in obstetrics and gynecology. The program has become the largest national network of peers supporting peers in the field and is reducing burnout and isolation through confidentiality and shared experiences. Peer supporters expanded their reach to provide both formal and informal support.
The Armed Forces District continued with its successful work on its ACOG Foundation grant program, Facilitating Effective Transitions: Addressing Burnout and Retention in Military Physicians.
The AFD Junior Fellows once again hosted their annual Simulation Festival at the 2024 ADM. Junior Fellows have presented 28 projects since the inaugural event in 2022. This annual event facilitates critical thinking in the development of novel simulation models, creative use of inexpensive materials and available medical supplies, new additions to previously created projects, and friendly competition. Topics included cervical ripening balloon placement, perineal laceration repair, surgical management of postpartum hemorrhage, dilation and evacuation, and obstetric anal sphincter repair. This event has garnered national scholarly recognition, including a peer-reviewed publication on development and success of the Simulation Festival, two oral presentations by residents at subsequent ADMs, and a first-place Junior Fellow Initiative Tool kit award in 2023 for a resident’s novel simulation model on perineal laceration repair.
67 physicians, residents, and medical students for group coaching with professional coaches
An online longitudinal coaching program with six sessions over 12 weeks
Coaching sessions conducted with four professional coaches: Holly Olson, MD, FACOG, who coached medical students; Cristin Mount, MD, who coached residents and the all-AFD group; Vanessa Calderon, MD, who coached Early-Career Fellows; and Amy Vertrees, MD, who coached AFD Fellows
The District XI Legislative Committee hosted lunch-and-learn sessions at the Texas state capitol, focusing on maternal mental health and diabetes. Additional sessions covering other key health topics are planned for the 89th Texas legislative session.
In 2024, residents submitted 68 abstracts to the resident research session, up from 46 in 2023. Of those, 50 were accepted for the poster session.
The abstract presented by Rachel Astles, MD, was selected as one of two winners of the 2024–25 Donald F. Richardson Memorial Prize Paper Award. This was a first for a District XII resident. Dr. Astles will present her paper, Intravenous Fluid in Labor and Delivery and Postpartum Hemorrhage and Blood Transfusion: A Retrospective Study, at the 2025 ACSM.
Abstract winner of the 2024–25 Donald F. Richardson Memorial Prize Paper Award
President
Stella M. Dantas, MD, FACOG
Treasurer
Grant R. Cox, MD, FACOG
Secretary
Camille A. Clare, MD, MPH, CPE, FACOG
Assistant Secretary
Marguerite P. Cohen, MD, FACOG
Chief Executive Officer
Sandra E. Brooks, MD, MBA, FACS, FACOG
Chair, District I
Erin T. Bradley, MD, MPH, FACOG
Chair, District II
Mary L. Rosser, MD, PhD, FACOG
Chair, District III
Gregory W. DeMeo, DO, FACOG
Chair, District IV
Scott A. Sullivan, MD, FACOG
Chair, District V
Wayne C. Trout, MD, FACOG
Chair, District VI
Tamara G. Helfer, MD, MBA, FACOG
Chair, District VII
Christopher T. Welsch, MD, FACOG
President-Elect
Steven J. Fleischman, MD, MBA, FACOG
Chair, District VIII
Ilana B. Addis, MD, MPH, FACOG
Chair, District IX
John P. McHugh, MD, FACOG
Chair, Armed Forces District
Monica A. Lutgendorf, MD, CAPT, MC, USN, FACOG
Chair, District XI
Gayle Olson Koutrouvelis, MD, MPH, FACOG
Chair, District XII
Julie Zemaitis DeCesare, MD, FACOG Fellow at Large
Pratima Gupta, MD, FACOG
Fellow at Large
Hector O. Chapa, MD, FACOG
Early-Career Fellow at Large
Emily R. Penick, MD, COL, MC USA, FACOG
Early-Career Fellow at Large
Niraj R. Chavan, MD, FACOG Chair, Junior Fellow College Advisory Council
Allen Ghareeb, MD, FACOG
Immediate Past President
Verda J. Hicks, MD, FACOG
Vice Chair, Junior Fellow College Advisory Council
Sivani Aluru, MD
Subspecialty Representative, American Urogynecologic Society
Elisa R. Trowbridge, MD, FACOG
Subspecialty Representative, SMFM
Fadi Bsat, MD, FACOG
Subspecialty Representative, Society for Reproductive Endocrinology and Infertility
Erica E. Marsh, MD, MSCI, FACOG
Subspecialty Representative, Society of Gynecologic Oncology
David I. Shalowitz, MD, MSHP, FACOG
Subspecialty Representative, Society of Family Planning
Anitra D. Beasley, MD, MPH, FACOG Public Member
Kimberly A. Butler, MPH
Dear Friends of the ACOG Foundation,
The ACOG Foundation proudly represents the charitable arm of our 62,000 ACOG members, who come from 12 Districts spanning the United States and eight other countries. Our goal is to promote educational and scientific programs that advance the health of people seeking obstetric and gynecologic care. Supporting the development and dissemination of community-based interventions, patient-facing educational materials, and hands-on trainings designed to improve access to reproductive care and providing training in emergency obstetrical care enables us to effect demonstrable change in these unprecedented times.
The vision we share with ACOG—to see an equitable world in which exceptional care is accessible to all—is important to highlight during this time of uncertainty. Access to the full spectrum of reproductive and gynecologic care is essential for people’s health, safety, and well-being. We, alongside our grantee partner organizations and our generous supporters, are committed to being a positive force for elevating patients’ health. Whether we’re supporting our patient-facing website that garnered over 12 million views in 2024, providing trainings on postpartum long-acting reversible contraception (LARC) to institutions around the country, or supporting ob-gyn trainings on postpartum hemorrhage at a hospital in Cameroon, we know that each intervention makes a difference.
The year ahead demands that we continue to deliver on the promise of our mission: to promote charitable, educational, and scientific initiatives that enable ACOG members and their colleagues to improve the lives of all people seeking ob-gyn care, their families, and communities. We are honored that you stand with us.
Warm regards, LETTER FROM THE CHAIR
Tamika Auguste
Tamika Auguste, MD, FACOG ACOG Foundation Chair
Launching the CREOG Inclusive Excellence Program, which is designed to train ob-gyn residents in promoting a supportive, inclusive work environment, with support from Hologic Foundation
Conducting 22 Effective Conversations about Abortion workshops and introducing a new support call resource to help individuals and small groups implement recommendations from the workshop
Providing 17 Postpartum Contraception Access Initiative trainings and implementation calls in 2024, a 42% increase from 2023. After hands-on clinical training and implementation support, 30 physicians at one institution in Texas are offering immediate postpartum LARC and have provided 138 patients with postpartum LARC.
Training 311 participants through the Optimizing Care for Pregnancy Loss Program, which focuses on the medication and procedural management of early pregnancy loss
Supporting ACOG’s patient website, which provides evidence-based, accessible medical information to the public. The website garnered more than 12 million views in 2024 and includes animated videos and significant amounts of content in Spanish.
Watching our first five grantee partners tackle postpartum hemorrhage in a Cameroon hospital, community-based doula care in Cleveland, severe hypertension in pregnancy in Idaho, access to reproductive care in underserved communities in Southern California, and burnout and attrition in ob-gyns in the military
The ACOG Foundation is pleased to announce its grantees for our 2024–25 grant award cycle. The ACOG Foundation Board of Directors awarded four new grants and two follow-on grants totaling $205,430.
Initiative: Understanding How the Maternity Access Crisis Is Impacting Patient Care in New York
This project seeks to analyze the effects of the maternity access crisis on patient care in New York by surveying ob-gyns across the state. The findings will be used to identify opportunities to improve patient safety and address disparities in care.
Amount: $50,000
Initiative: The Teen Promise Project
This program educates middle school students on healthy relationships and sexual and reproductive health to reduce adolescent pregnancy rates. It is led by medical students in collaboration with ob-gyn and pediatrics physicians and local middle schools.
Amount: $42,088
Initiative: Lake Zone Fistula Program: Expanding High-Quality Obstetric Fistula Care in Tanzania
The Lake Zone Fistula Program in Tanzania aims to enhance the quality of life for women with obstetric fistula and build long-term capacity for health care professionals. The program will facilitate 100 life-transforming fistula surgeries; upskill two fistula surgeons; train 80 community health workers; and reach 100,000 community members.
Amount: $50,000
Initiative: Group Prenatal Care Program at the University of Miami
The Group Prenatal Care Program at the University of Miami Jackson Health System aims to collect preliminary data on patient health outcomes and satisfaction. This initiative seeks to reduce clinician bias and maternal health disparities by fostering increased patient–physician contact and implementing a patient-led agenda.
Amount: $48,342
Initiative: Implementing an OB Hemorrhage Bundle in Cameroon: Stage 2
This is a continuation grant for the project at the Regional Hospital Limbe in Cameroon, a 2023–24 project designed to reduce preventable maternal mortality and severe maternal morbidity, pursue scholarly examination of the project, and potentially expand to another facility.
Amount: $10,000
Initiative: Facilitating Effective Transitions: Addressing Burnout and Retention in Military Physicians
This is a continuation grant to examine the effects of burnout and other challenges facing ob-gyns and help promote well-being of ob-gyns in the military.
Amount: $5,000
Chair
Tamika Auguste, MD, FACOG
Secretary
Robert H. Palmer Jr, MD, FACOG
Treasurer
David W. Doty, DO, FACOG
Designated Directors
Anne L. Banfield, MD, FACOG
Bridget Keller, MD, FACOG
Ex Officio Designated Director
Verda J. Hicks, MD, FACOG
Ex Officio Director
Sandra E. Brooks, MD, MBA, FACS, FACOG
ACOG
Note: In July 2024, ACOG Foundation changed the names of its donor societies and giving levels. For the purposes of this report, we are including all donors who contributed at what was previously the Reis Society level and above in this acknowledgement list.
Visionary Hologic Foundation
Ambassador
Sandra E. Brooks, MD, MBA, FACOG, and Garth M. Beache, MD
Steven J. Fleischman, MD, MBA, FACOG
Cassandra E. Henderson, MD, MSc, CDCES, FACOG
Investor
Rita W. Driggers, MD, FACOG, and Christopher M. Zahn, MD, FACOG
Jenna L. Tjossem-Robb, MD, FACOG
Steward
Anne L. Banfield, MD, FACOG
Ilana B. Addis, MD, MPH, FACOG
Daniel M. Breitkopf, MD, FACOG
Camille A. Clare, MD, MPH, CPE, FACOG
Shanna Marie Combs, MD, FACOG
Stella M. Dantas, MD, FACOG
Sandra D. Dayaratna, MD, FACOG
Joseph T. Edwards, MD, FACOG
Melanie and Thomas Gellhaus, MD, FACOG
Lisa M. Hollier, MD, MPH, FACOG
David Johnson, IOM, CAE, FASAE
Magdalene B. Karon, MD, FACOG
Bridget B. Keller, MD, FACOG
Gloria H. Martin, PhD
G. Sealy Massingill, MD, FACOG
Wade A. Neiman, MD, FACOG
Lila V. Nevrekar, MD, FACOG
Robert H. Palmer Jr, MD, FACOG
Todd A. Pankratz, MD, FACOG
Heather Z. Sankey, MD, FACOG
Theodore D. Segal and
Joyce R. Wasserstein, PhD
Ally
Aaron B. Caughey, MD, MPH, PhD, FACOG
Clayton H. McCracken III, MD, FACOG
Ted L. Anderson, MD, PhD, FACOG
Joseph J. Apuzzio, MD, FACOG
Amy J. Asato, MD, FACOG
Tamika C. Auguste, MD, FACOG
Rob Batarla, MBA, CPA
May H. Blanchard, MD, FACOG
Constance Bohon, MD, FACOG
William Bradford, DO
Eva Chalas, MD, FACOG
AnnaMarie Connolly, MD, FACOG
Grant R. Cox, MD, FACOG
Kendra Davis
Julie Zemaitis DeCesare, MD, FACOG
Kimberly M. DeVore, DO, FACOG
Vivian M. Dickerson, MD, FACOG
David W. Doty, DO, FACOG
Don A. Dyer, MD, FACOG
Julius R. Ellis, MD, FACOG
Marygrace Elson, MD, MME, FACOG
Maureen E. Farrell, MD, FACOG
Karen L. Florio, DO, FACOG
Lisa M. Foglia, MD, FACOG
Anne F. Foster, MD, FACOG
Snehanshu Ghosh, MD, FACOG, and Rosario A. Carmona, MD, FACOG
Joseph G. Gianfortoni, MD, FACOG
Cole D. Greves, MD, FACOG
William H. J. Haffner, MD, FACOG
Keith A. Hansen, MD, FACOG
Karen E. Harris, MD, MPH, FACOG
Carla G. Hawley-Bowland, MD, FACOG
Tamara Gammill Helfer, MD, MBA, FACOG
Christine M. Herde, MD, FACOG
Iffath A. Hoskins, MD, FACOG
Gerald F. Joseph Jr, MD, FACOG
Leah Kaufman, MD, FACOG
Judith Mara Kimelman, MD, FACOG
Douglas H. Kirkpatrick, MD, FACOG
Susan D. Klugman, MD FACOG
Sandra Koch, MD, FACOG
Gayle Koutrouvelis, MD, MPH, FACOG
Latifa Compoare Salifu
Dawn Holdren
Judy Levison, MD, MPH, FACOG
J. Martin Tucker, MD, FACOG, and Robin Tucker
Maryanne McDonnell, MD, FACOG
Timothy C. McFarren, MD, FACOG
John P. McHugh, MD, FACOG
Molly Meegan, JD
Joseph Ogburn, MD
Holly L. Olson, MD, FACOG
Sarah M. Page-Ramsey, MD, FACOG
D. Paul Seago, MD, FACOG
Sarah W. Prager, MD, FACOG
Patrick S. Ramsey, MD, MSPH, FACOG
Monique M. Regard, MD, FACOG
Isaac Schiff, MD, FACOG
Sharuk Noor Ali
Heather A. Smith, MD, FACOG
Kirsten M. Smith, MD, FACOG
Scott A. Sullivan, MD, FACOG
Maria Teresa Tam, MD, FACOG
Terrie Platt, DNP
Jennifer Walsh
Louise R. Wannamaker, MD, FACOG
Christopher T. Welsch, MD, FACOG
Fund the Future Society
Matthew T. Allswede, MD, FACOG
Lisa Renee Blackwood, MD, FACOG
Rachel Kathleen Bowman, MD, FACOG
James T. Breeden, MD, FACOG, and Midge Breeden
Sandra A. Carson, MD, FACOG
Ying Chan, MD, FACOG
Anna M. D’Amico, MD, FACOG
Leonard S. Fagan, MD, FACOG
Karin Anneliese Fox, MD, FACOG
Herbert Guzman, MD, FACOG
W. Benson Harer Jr, MD, FACOG
Scott D. Hayworth, MD, FACOG, and Nan Hayworth
Sarah Katherine Horvath, MD, MSHP, FACOG
Alan T. Kent, MD
Robin D. Matthews, MD, FACOG
Megan McReynolds
Patricia M. Miller, MD
Anson Gregory Nebeker
Thomas F. Purdon, MD, FACOG, and Kathryn M. Purdon
Susana Schwarz, MD, FACOG
Paul A. Smurda, MD, FACOG
Doris E. Tirado, MD, FACOG
Eugene C. Toy, MD, FACOG
Mary F. Vanko, MD, FACOG
Kristy K. Ward, MD, FACOG
Jenny White
ACOG deeply appreciates the support we received from the following philanthropic supporters in 2024.
ACOG/ACOG Foundation 2024 financial statements (unaudited) as of May 2025.
ACOG programs continue to provide the necessary resources to serve our members and improve health care for those seeking obstetric and gynecologic care. Included in these financial statements are the activities of ACOG, the ACOG Foundation, 93 ACOG Districts and 12 Sections, and the ACOG Landholding Corporation. Operating revenues of just over $66 million were led by member dues, federal cooperative agreements, Obstetrics & Gynecology, and the Annual Clinical & Scientific Meeting in San Francisco, California. Expenses of $70.9 million reflect our investment in the education and advancement of our members, reliable and relevant scientific research, medical practice support, and support for current and emerging issues in the field. In 2024, the ACOG portfolio returned significant gains, similar to 2023. The investment portfolio is continually monitored with a goal of funding ACOG’s long-term needs without subjecting the organization to excessive risk. ACOG’s combined operating and nonoperating activity resulted in a net income of just under $17.0 million for the year. To fund strategic initiatives in support of ACOG’s mission, vision, and values; support the operations of our Districts and Sections; and protect against business disruptions, ACOG held financial reserves and endowments of $190.8 million.
ASSETS
Cash and cash equivalents $18,959,939 Accounts receivable, inventory, and prepaid expenses 409,461 Investments
OPERATING REVENUE
Dues and fees $28,564,100
Meeting registration, exhibits, and tuition
Contributions
Salaries and benefits $28,971,546
Meetings and travel 15,855,909